-
3 Apr 2024 Job Information Organisation/Company UNIVERSIDAD AUTÓNOMA DE MADRID Research Field Other Researcher Profile First Stage Researcher (R1) Country Spain Application Deadline 8 Apr 2024 - 00
-
2 Apr 2024 Job Information Organisation/Company UNIVERSIDAD AUTÓNOMA DE MADRID Research Field Computer science » Other Researcher Profile First Stage Researcher (R1) Country Spain Application
-
, the Universidad Autónoma de Madrid, the Healthcare Advisory Council of the Community of Madrid and the Foundation for Biomedical Research of Hospital Universitario La Paz, which will be the managing body
-
IdiPAZ seeks Degree in Biotechnology with a Master's Degree in Clinical Trial Monitoring (ERA4TBAB).
Research Institute is the result of a partnership between the Hospital Universitario La Paz, the Universidad Autónoma de Madrid, the Healthcare Advisory Council of the Community of Madrid and the Foundation
-
Universitario La Paz, the Universidad Autónoma de Madrid, the Healthcare Advisory Council of the Community of Madrid and the Foundation for Biomedical Research of Hospital Universitario La Paz, which will be
-
of a partnership between “La Paz” University Hospital, Universidad Autónoma de Madrid, the Healthcare Public Service of the Madrid Autonomous Region and the Foundation for Biomedical Research of La Paz
-
head and neck cancer. The IdiPAZ Health Research Institute is the result of a partnership between the Hospital Universitario La Paz, the Universidad Autónoma de Madrid, the Healthcare Advisory Council
-
Health Research Institute is the result of a partnership between the Hospital Universitario La Paz, the Universidad Autónoma de Madrid, the Healthcare Advisory Council of the Community of Madrid and the
-
Research Institute is the result of a partnership between “La Paz” University Hospital, Universidad Autónoma de Madrid, the Healthcare Public Service of the Madrid Autonomous Region and the Foundation
-
result of a partnership between the Hospital Universitario La Paz, the Universidad Autónoma de Madrid, the Healthcare Advisory Council of the Community of Madrid and the Foundation for Biomedical Research